REXIMMUNE-C
Live / Registered — Registered and renewed (as of 13 Feb 2017)
What this means for you
Registered since 24 Jul 2007. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 24 Jul 2017).
Record
- Serial number
- 78706667
- Registration number
- 3269885
- Mark type
- Stylized text
- Filed
- 03 Sept 2005
- Published for opposition
- 25 Jul 2006
- Registered
- 24 Jul 2007
- Next maintenance due
- 24 Jul 2017
- Attorney of record
- Jean L. Batman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, lesion-targeted vectory carrying immune response genes for use in the treatment of cancer, inflammatory and immunologic disorders
Owner
- GENVIVO, INC., SAN MARINO, CA, US
- Epeius Biotechnologies Corporation, San Marino, CA, US
- Epeius Biotechnologies Corporation, San Marino, CA, US
- Epeius Biotechnologies Corporation, Monrovia, CA, US
Prosecution history
- 30 Jan 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 13 Feb 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 13 Feb 2017 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 13 Feb 2017 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 08 Feb 2017 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 05 Dec 2016 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 05 Dec 2016 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Sept 2016 — TEAS SECTION 8 & 9 RECEIVED
- 24 Jul 2016 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 19 Dec 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 19 Dec 2013 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 10 Dec 2013 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 19 Dec 2013 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Dec 2013 — TEAS SECTION 8 & 15 RECEIVED
- 20 Nov 2008 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED